Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Oramed Pharmaceuticals reported a significant increase in net income to $134.9 million for the nine months ended September 30, 2026, primarily driven by $180.5 million in financial income. The company's total assets grew to $400.9 million, largely due to substantial increases in the fair value of investments and associates.
Corteva, Inc. filed combined financial statements for 'New Corteva' (its Crop Protection Business) following the October 1, 2026, spin-off of its Seed Business into Vylor Inc. The filing provides historical and interim financial results for the three and nine months ended September 30, 2026, reflecting the new corporate structure where Vylor is treated as the accounting successor.
Tamboran Resources reported total assets of $1.2 billion as of September 30, 2026, with initial gas sales commencing in September 2026. The company remains in an early development stage with an accumulated deficit of $205.5 million and a net loss for the period, though it maintains a cash position of $160.1 million to fund ongoing Beetaloo Basin operations.
Akari Therapeutics reported third quarter 2026 financial results and highlighted the initiation of GLP toxicology studies for its lead TROP2-targeted ADC candidate, AKTX-101. The company ended the quarter with $5.7 million in cash and is progressing toward a planned Phase 1 clinical trial in mid-2027, subject to additional financing.
Term
Q3 2026
“We are entering an increasingly important phase in Akari’s evolution, as we translate the differentiated potential of our PH1 payload platform into a defined path toward clinical development. The initiation of GLP toxicology studies represents a critical step toward bringing AKTX-101 into the clinic.”
Abizer Gaslightwala, President and Chief Executive Officer
“The ADC landscape is rapidly evolving, and we believe the next wave of innovation will be driven not simply by new targets, but by novel payloads capable of overcoming the limitations of current treatments. That is precisely the opportunity we are pursuing with the PH1 payload.”
Abizer Gaslightwala, President and Chief Executive Officer
Rank One Computing (ROC) reported record third-quarter 2026 revenue of $8.0 million, a 50% year-over-year increase, and achieved quarterly profitability. The company highlighted significant federal traction, including a $64.3 million Department of Justice contract for its ROC Evidence platform, the largest in its history.
Term
Q3 2026
“The third quarter marked a transformational period for ROC, highlighted by record revenue, a profitable quarter, and significant execution against the strategic objectives we established at our IPO.”
B. Scott Swann, ROC’s Chief Executive Officer
“Importantly, we delivered on our commitment by establishing two foundational federal beachhead contracts for ROC ABIS and ROC Evidence, including the largest award in ROC’s history, a $64.3 million contract with the U.S. Department of Justice.”
iAnthus Capital Holdings reported Q3 2026 revenue of $38.4 million, a sequential increase of $3.0 million from the previous quarter. The company also announced a change in its independent registered public accounting firm, appointing Macias Gini & O’Connell LLP to replace PKF O’Connor Davies, LLP for the 2026 fiscal year.
John Hancock Comvest Private Income Fund reported a net increase in net assets resulting from operations of $32.68 million for the nine months ended September 30, 2026. A significant highlight was the merger with Manulife Private Credit Fund on September 30, 2026, which added $328.8 million in total assets and resulted in the issuance of approximately 6.6 million Class I common shares.
Southland Holdings reported a net income of $34.7 million for the third quarter of 2026, a significant recovery from a $77.0 million loss in the prior year period. However, the company faces a year-to-date net loss of $80.6 million and a total stockholders' deficit of $219.6 million as of September 30, 2026.
Elite Pharmaceuticals reported financial results for its second fiscal quarter ended September 30, 2026, with revenue increasing 10.4% to $40.1 million. The growth was driven by the company's Elite label amphetamine and naltrexone product lines, leading to a 21% increase in operating income to $9.9 million.
Sekisui House U.S., Inc. reported a net loss of $1.7 million for the quarter ended September 30, 2026, compared to a net income of $34.1 million in the prior year period. Total homebuilding revenues decreased significantly to $1.24 billion from $1.54 billion year-over-year, primarily driven by lower home sale revenues.
Tamboran Resources Corporation reported its financial and operating results for the first quarter of fiscal year 2027, ended September 30, 2026. The company released an earnings presentation and press release detailing its strategic progress in the Beetaloo Basin. The filing includes management's forward-looking statements regarding future reserves, production plans, and capital requirements for development programs.
Southland Holdings reported Q3 2026 financial results, swinging to a net income of $33.7 million from a significant loss in the prior year period. Results were bolstered by $28.7 million in other income from a settlement with Liberty Mutual related to the Washington State Convention Center Project and a 9.6% increase in revenue.
“Our third quarter results reflect continued execution of our strategic plan and an improvement in our operating performance. During the quarter, we improved gross margin to 8.8%, delivered operating income of $7.0 million, and grew our backlog to $1.71 billion. This marks meaningful progress, and we remain focused on the work ahead. Demand for our services continues to be strong, and we believe Southland is well positioned to convert its share of new opportunities into profitable awards.”
Frank Renda, Southland’s President & Chief Executive Officer
Aetherion Technologies reported a 60% increase in Q3 2026 revenue to $2.6 million, driven by normalized production in China and Canada. The company significantly reduced its net loss from continuing operations to $3.0 million, aided by improved performance from its Cespira investment and a $2.2 million gain on warrant liabilities. Cash reserves stood at $14.5 million following the full repayment of EDC debt during the quarter.
B&R Technology Merger Corp. is a special purpose acquisition company (SPAC) that completed its IPO on July 22, 2026, raising $360 million held in a trust account. As of September 30, 2026, the company reported total assets of $363.6 million and is currently seeking a business combination within a 24-month window.
Willow Tree Capital Corp reported total investment income of $67.2 million and net investment income of $31.2 million for the nine months ended September 30, 2026. The company's net asset value per share decreased slightly to $15.97 from $16.11 at the end of 2025, while total assets grew to $970.1 million.
Energous Corp reported a significant revenue increase to $9.57 million for the first nine months of 2026, up from $2.59 million in 2025, driven by its Wireless Power Network technology. Despite the growth, the company remains loss-making with a net loss of $7.08 million, though it significantly strengthened its cash position to $28.83 million through ATM equity offerings.
Muzinich BDC, Inc. reported a net decrease in net assets resulting from operations of $1.77 million for the nine months ended September 30, 2026, primarily driven by $17.8 million in realized losses on non-controlled investments. Despite these losses, the company maintained a net asset value per share of $765.19 and generated $7.12 million in net investment income during the same period.
For the nine months ended September 30, 2026, Muzinich Corporate Lending Income Fund reported net investment income of $4.69 million and a net increase in net assets from operations of $4.92 million. Total net assets grew to $103.1 million, driven by $5.0 million in common share issuances and positive investment performance despite a $221,515 management fee waiver.
Corteva, Inc. reported net sales of $2,458 million for the third quarter of 2026, a decrease from $2,618 million in the prior year period. The company experienced a net loss attributable to Corteva of $570 million for the quarter, impacted by $99 million in separation costs related to the spin-off of its Seed Business (Vylor) on October 1, 2026.
For the nine months ended September 30, 2026, Corteva reported net sales of $13,742 million, a slight increase from $13,491 million in the prior year. However, net income attributable to Corteva decreased to $1,311 million compared to $1,646 million in 2025, primarily driven by higher separation costs and a loss from continuing operations in the third quarter. The company also completed the separation of its Seed business (Vylor) on October 1, 2026.
Longeveron Inc. reported Q3 2026 financial results and announced it has initiated a formal process to review strategic alternatives, including a potential sale, merger, or business combination. The company has retained Lucid Capital Markets as its financial advisor and is seeking a meeting with the FDA to discuss next steps for its HLHS program following Phase 2b trial results.
“With ELPIS II results now available, we have requested a meeting with the FDA to determine potential next steps for the HLHS development program. At the same time, we continue to review potential strategic alternatives for the Company as we explore all opportunities to maximize value for our stockholders.”
For the nine months ended September 30, 2026, Oragenics reported a net loss of $7.3 million, a slight improvement from the $7.6 million loss in the prior year period. The company's cash position decreased significantly to $2.2 million from $4.4 million at year-end 2025, primarily due to increased research and development spending on its lead product candidate, ONP-002.
ADI Global Distribution Inc. reported a net loss of $655 million for the quarter ended October 3, 2026, primarily driven by a $659 million non-cash goodwill impairment charge. Despite the net loss, net revenue grew to $1.31 billion compared to $1.20 billion in the prior year period, and the company completed its spin-off from its former parent during the quarter.
For the nine months ended September 30, 2026, Ascend Wellness Holdings reported a net loss of $67.3 million on revenue of $373.1 million, a slight revenue decrease compared to the prior year. Despite an operating profit of $12.3 million, the company was impacted by $63.0 million in interest expense and significant income tax expenses.
Cerebras Systems Inc. reported a significant increase in total assets to $11.9 billion as of September 30, 2026, driven by substantial growth in cash, investments, and property and equipment. The company's balance sheet reflects a major capital infusion following its IPO, with cash and investments totaling over $7.3 billion compared to $1.1 billion at the end of 2025.
Avidia Bancorp reported net income of $8.6 million for the third quarter of 2026, a significant recovery from a net loss of $0.9 million in the prior year period. The improvement was driven by higher net interest income and a substantial reduction in credit loss expenses, although the company experienced a decrease in total stockholders' equity due to share repurchases and unrealized losses on securities.
Commercial Bancgroup, Inc. reported 13,710,195 shares of common stock outstanding as of November 12, 2026. The filing highlights key risks including loan concentrations in real estate and geographic exposure in Kentucky, North Carolina, and Tennessee, while maintaining its status as an emerging growth company and smaller reporting company.
Nocopi Technologies reported Q3 2026 financial results with total revenue increasing 763% to $3.3 million, driven by an early license renewal and the acquisition of Polymeric. The company achieved net income of $1.4 million compared to a net loss in the prior year period, ending the quarter with $10.3 million in cash and no debt.
Agassi Sports Entertainment Corp. reported a net loss of $5.54 million for the nine months ended September 30, 2026, compared to a $2.76 million loss in the prior year. The company is currently pre-revenue, focusing on the development of its court sports platform and 'Let's Play' pickleball facilities while operating with a significant accumulated deficit of $45.17 million.
TAP Real Estate Technologies, Inc. (formerly HUMBL, Inc.) reported a net loss of $5,821,491 for the nine months ended September 30, 2026, compared to a net loss of $7,053,580 in the prior year period. The company generated its first revenues of $60,982 during the current period while significantly reducing operating expenses from $6.26 million to $3.29 million.